COMMONWEALTH BIOTECHNOLOGIES, INC.

Company

Inhibitor Therapeutics, Inc.

Filed

April 15, 2003

Period of Report

May 15, 2003

Accession Number

0000916641-03-001039

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →